Related Experiment Video
Updated: Jun 26, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Differential Infectivity of Original and Delta Variants of SARS-CoV-2 in Children Compared to Adults
Lauren Garnett1,2, Carmen Tse3, Duane Funk4
1Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canadagrid.415368.d, Winnipeg, Manitoba, Canada.
Insights
Children infected with the Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more likely to spread infectious virus. This suggests children may play a larger role in Delta variant transmission compared to earlier strains.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Children were previously considered less significant drivers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission.
- The role of pediatric populations in the transmission dynamics of new SARS-CoV-2 variants of concern (VOC), like the Delta variant, remains largely unknown.
Purpose of the Study:
- To investigate differences in viral RNA and viable virus levels between children infected with the Delta variant versus original variants (OV).
- To compare pediatric SARS-CoV-2 infection trends with those observed in adults.
Main Methods:
- Analysis of 690 SARS-CoV-2 RT-PCR positive nasopharyngeal swabs from Manitoba, Canada.
- Screening for mutations characteristic of VOC.
- Determination of infectious titers using 50% tissue culture infective dose (TCID50) assays.
Main Results:
- Children infected with the Delta variant were 2.7 times more likely to produce viable SARS-CoV-2 with higher infectious titers compared to those with OV, irrespective of viral RNA levels.
- Pediatric Delta variant samples showed infectious titers comparable to those of culture-positive adult samples.
Conclusions:
- Children may contribute more significantly to the transmission of the SARS-CoV-2 Delta variant than previously circulating variants.
- Findings may elucidate a mechanism for the Delta variant's predominance.
Abstract:
Although children of all ages are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, they have not been implicated as major drivers of transmission thus far. However, it is still unknown if this finding holds true with new variants of concern (VOC), such as Delta (B.1.617.2). This study aimed to examine differences in both viral RNA (as measured by cycle threshold [C]) and viable-virus levels from children infected with Delta and those infected with original variants (OV). Furthermore, we aimed to compare the pediatric population infection trends to those in adults. We obtained 690 SARS-CoV-2 RT-PCR positive nasopharyngeal swabs from across Manitoba, Canada, which were further screened for mutations characteristic of VOC. Aliquots of sample were then provided for TCID50 (50% tissue culture infective dose) assays to determine infectious titers. Using a variety of statistical analyses we compared C and infectivity of VOC in different age demographics. Comparing 122 Delta- to 175 OV-positive nasopharyngeal swab samples from children, we found that those infected with Delta are 2.7 times more likely to produce viable SARS-CoV-2 with higher titers (in TCID50 per milliliter), regardless of viral RNA levels. Moreover, comparing the pediatric samples to 130 OV- and 263 Delta-positive samples from adults, we found only that the Delta pediatric culture-positive samples had titers (TCID50 per milliliter) similar to those of culture-positive adult samples. IMPORTANCE These important findings show that children may play a larger role in viral transmission of Delta than for previously circulating SARS-CoV-2 variants. Additionally, they may suggest a mechanism for why Delta has evolved to be the predominant circulating variant.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Coronavirus
Respiratory Syncytial Virus Disease